Wikidata entity: Q58376
C₂₂H₂₆F₃N₃OS (P274)
Quantities
| P4250 | defined daily dose | 1 |
| P4250 | defined daily dose | 10 |
| P2067 | mass | 437.174868 |
| P233 | canonical SMILES | String | C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO | ??? |
| P373 | Commons category | String | Fluphenazine | ??? |
| P527 | has part(s) | ... | Q556 (hydrogen) | hydrogen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q650 (fluorine) | fluorine |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q682 (sulfur) | sulfur |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Fluphenazine-xtal-2012-ball-and-stick.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P2175 | medical condition treated | ... | Q41112 (schizophrenia) | schizophrenia |
| P2175 | medical condition treated | ... | Q2157462 (schizophreniform disorder) | schizophreniform disorder |
| P129 | physically interacts with | ... | Q1949517 (5-hydroxytryptamine receptor 2A) | 5-hydroxytryptamine receptor 2A |
| P129 | physically interacts with | ... | Q2034004 (Dopamine receptor D2) | Dopamine receptor D2 |
| P129 | physically interacts with | ... | Q309513 (Histamine receptor H1) | Histamine receptor H1 |
| P129 | physically interacts with | ... | Q21109355 (5-hydroxytryptamine receptor 7) | 5-hydroxytryptamine receptor 7 |
| P129 | physically interacts with | ... | Q21109363 (5-hydroxytryptamine receptor 6) | 5-hydroxytryptamine receptor 6 |
| P129 | physically interacts with | ... | Q21110867 (Dopamine receptor D1) | Dopamine receptor D1 |
| P129 | physically interacts with | ... | Q21131500 (Dopamine receptor D5) | Dopamine receptor D5 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P636 | route of administration | ... | Q432083 (intramuscular injection) | intramuscular injection |
| P769 | significant drug interaction | ... | Q568 (lithium) | lithium |
| P769 | significant drug interaction | ... | Q174723 (codeine) | codeine |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q409761 (amantadine) | amantadine |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q55434 (pethidine) | pethidine |
| P769 | significant drug interaction | ... | Q413581 (bromocriptine) | bromocriptine |
| P769 | significant drug interaction | ... | Q416206 (pentamidine) | pentamidine |
| P769 | significant drug interaction | ... | Q300989 (levodopa) | levodopa |
| P769 | significant drug interaction | ... | Q2622907 (periciazine) | periciazine |
| P769 | significant drug interaction | ... | Q58614 (loxapine) | loxapine |
| P769 | significant drug interaction | ... | Q81225 (morphine) | morphine |
| P769 | significant drug interaction | ... | Q423308 (cabergoline) | cabergoline |
| P769 | significant drug interaction | ... | Q423364 (propranolol) | propranolol |
| P769 | significant drug interaction | ... | Q303646 (hydromorphone) | hydromorphone |
| P769 | significant drug interaction | ... | Q377270 (dihydrocodeine) | dihydrocodeine |
| P769 | significant drug interaction | ... | Q407535 (oxycodone) | oxycodone |
| P769 | significant drug interaction | ... | Q407541 (fentanyl) | fentanyl |
| P769 | significant drug interaction | ... | Q407592 (tramadol) | tramadol |
| P769 | significant drug interaction | ... | Q407721 (buprenorphine) | buprenorphine |
| P9989 | stylized name | String | fluPHENAZine | ??? |
| P279 | subclass of | ... | Q2832210 (primary alcohol) | primary alcohol |
| P279 | subclass of | ... | Q16023748 (phenothiazine) | phenothiazine |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q208144 (antipsychotics) | antipsychotics |
| P2868 | subject has role | ... | Q1927838 (alpha blocker) | alpha blocker |
| P2868 | subject has role | ... | Q3271533 (dopamine antagonist) | dopamine antagonist |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | fluphenazine | ??? |
Why not click here or view trends?
log id: 2337222